Federal Register / Vol. 70, No. 20 / Tuesday, February 1, 2005 / Notices 5195

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy.

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel, 

Imaging and Mood Disorders. 

Date: February 23, 2005. 

Time: 12 p.m. to 1:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Telephone 

conference call). 

Contact Person: Peter J. Sheridan, PhD, 

Scientific Review Administrator, Division of 

Extramural Activities, National Institute of 

Mental Health, NIH, Neuroscience Center, 

6001 Executive Blvd., Room 6142, MSC 9606, 

Bethesda, MD 20892–9606, 301–443–1513, 

psherida@mail.nih.gov.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.242, Mental Health Research 

Grants; 93.281, Scientist Development 

Award, Scientist Development Award for 

Clinicians, and Research Scientist Award; 

93.282, Mental Health National Research 

Service Awards for Research Training, 

National Institutes of Health, HHS)

Dated: January 26, 2005. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 05–1839 Filed 1–31–05; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Disorders; 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. appendix 2) notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The purpose of this 

meeting is to evaluate requests for 

preclinical development resources for 

potential new therapeutics for type 1 

diabetes. The outcome of the evaluation 

will be a decision whether NIDDK 

should support the request and make 

available contract resources for 

development of the potential 

therapeutic to improve the treatment or 

prevent the development of type 1 

diabetes and its complications. The 

research proposals and the discussions 

could disclose confidential trade secrets 

or commercial property such as 

patentable material, and personal 

information concerning individuals 

associated with the proposed research 

projects, the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy.

Name of Committee: Type 1 Diabetes—

Rapid Access to Intervention Development 

Special Emphasis Panel, National Institute of 

Diabetes and Digestive and Kidney Diseases. 

Date: February 9, 2005. 

Time: 10 a.m.–2 p.m. 

Agenda: To evaluate requests for 

preclinical development resources for 

potential new therapeutics for type 1 diabetes 

and its complications. 

Place: 6707 Democracy Boulevard, 

Bethesda, MD 20892 (Telephone conference 

call). 

Contact Person: Dr. Myrlene Staten, Senior 

Advisor, Diabetes Translation Research, 

Division of Diabetes, Endocrinology and 

Metabolic Diseases, NIDDK, NIH, 6707 

Democracy Boulevard, Bethesda, MD 20892–

5460, 301–402–7886. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Disease and Nutrition 

Research; 98.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS)

Dated: January 26, 2005. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle.

[FR Doc. 05–1840 Filed 1–31–05; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Disorders; 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. appendix 2) notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The purpose of this 

meeting is to evaluate requests for 

preclinical development resources for 

potential new therapeutics for type 1 

diabetes. The outcome of the evaluation 

will be a decision whether NIDDK 

should support the request and make 

available contract resources for 

development of the potential 

therapeutic to improve the treatment or 

prevent the development of type 1 

diabetes and its complications. The 

research proposals and the discussions 

could disclose confidential trade secrets 

or commercial property such as 

patentable material, and personal 

information concerning individuals 

associated with the proposed research 

projects, the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy.

Name of Committee: Type 1 Diabetes—

Rapid Access to Intervention Development 

Special Emphasis Panel, National Institute of 

Diabetes and Digestive and Kidney Diseases. 

Date: February 18, 2005. 

Time: 2 a.m.–4 p.m. 

Agenda: To evaluate requests for 

preclinical development resources for 

potential new therapeutics for type 1 diabetes 

and its complications. 

Place: 6707 Democracy Boulevard, 

Bethesda, MD 20892 (Telephone conference 

call). 

Contact Person: Dr. Myrlene Staten, Senior 

Advisor, Diabetes Translation Research, 

Division of Diabetes, Endocrinology and 

Metabolic Diseases, NIDDK, NIH, 6707 

Democracy Boulevard, Bethesda, MD 20892–

5460, (301) 402–7886.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research, 98.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS)

Dated: January 26, 2005. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 05–1842 Filed 1–31–05; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Library of Medicine; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

5196 Federal Register / Vol. 70, No. 20 / Tuesday, February 1, 2005 / Notices 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy.

Name of Committee: National Library of 

Medicine Special Emphasis Panel; 

Biomedical Informatics. 

Date: March 22, 2005. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road, NW., 

Washington, DC 20015. 

Contact Person: Hua-Chuan Sim, MD, 

Scientific Review Administrator, National 

Library of Medicine, Extramural Programs, 

6705 Rockledge Drive, Suite 301, Bethesda, 

MD 20892.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.879, Medical Library 

Assistance, National Institutes of Health, 

HHS)

Dated: January 25, 2005. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 05–1831 Filed 1–31–05; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Library of Medicine; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C.. appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy.

Name of Committee: National Library of 

Medicine Special Emphasis Panel, IAIMS. 

Date: March 11, 2005. 

Time: 1 pm. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Library of Medicine, 

Building 38, Board Room, 2nd Floor, 8600 

Rockville Pike, Bethesda, MD 20892. 

Contact Person: Hua-Chuan Sim, MD, 

Scientific Review Administrator, National 

Library of Medicine, Extramural Programs, 

6705 Rockledge Drive, Suite 301, Bethesda, 

MD 20892.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.879, Medical Library 

Assistance, National Institutes of Health, 

HHS)

Dated: January 25, 2005. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 05–1832 Filed 1–31–05; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Library of Medicine; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy.

Name of Committee: National Library of 

Medicine Special Emphasis Panel; R21’s. 

Date: March 4, 2005. 

Time: 8 a.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Hua-Chuan Sim, MD, 

Scientific Review Administrator, National 

Library of Medicine, Extramural Programs, 

6705 Rockledge Drive, Suite 301, Bethesda, 

MD 20892.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.879, Medical Library 

Assistance, National Institutes of Health, 

HHS)

Dated: January 25, 2005. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 05–1833 Filed 1–31–05; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Library of Medicine; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. appendix 2), notice 

is hereby given of the following 

meeting. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy.

Name of Committee: National Library of 

Medicine Special Emphasis Panel, 

Publications (G13s). 

Date: February 25, 2005. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Hua-Chuan Sim, MD, 

Health Science Administrator, National 

Library of Medicine, Extramural Programs, 

6705 Rockledge Drive, Suite 301, Bethesda, 

MD 20892.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.879, Medical Library 

Assistance, National Institutes of Health, 

HHS)

Dated: January 25, 2005. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 05–1834 Filed 1–31–05; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. appendix 2), notice 

is hereby given of the following 

meetings. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and